NZ234476A - Paf antagonist thienodiazepine derivatives; intermediates, pharmaceutical compositions and preparatory processes - Google Patents

Paf antagonist thienodiazepine derivatives; intermediates, pharmaceutical compositions and preparatory processes

Info

Publication number
NZ234476A
NZ234476A NZ234476A NZ23447690A NZ234476A NZ 234476 A NZ234476 A NZ 234476A NZ 234476 A NZ234476 A NZ 234476A NZ 23447690 A NZ23447690 A NZ 23447690A NZ 234476 A NZ234476 A NZ 234476A
Authority
NZ
New Zealand
Prior art keywords
intermediates
pharmaceutical compositions
paf antagonist
preparatory processes
thienodiazepine
Prior art date
Application number
NZ234476A
Inventor
Karl-Heinz Weber
Werner Stransky
Gerhard Walther
Ulrike Kufner-Muhl
Franz Birke
Wolf-Dietrich Bechtel
Hubert Heuer
Gojko Muacevic
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NZ234476A publication Critical patent/NZ234476A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
NZ234476A 1989-07-12 1990-07-12 Paf antagonist thienodiazepine derivatives; intermediates, pharmaceutical compositions and preparatory processes NZ234476A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3922944 1989-07-12
DE4011345 1990-04-07

Publications (1)

Publication Number Publication Date
NZ234476A true NZ234476A (en) 1992-08-26

Family

ID=25882911

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ234476A NZ234476A (en) 1989-07-12 1990-07-12 Paf antagonist thienodiazepine derivatives; intermediates, pharmaceutical compositions and preparatory processes

Country Status (14)

Country Link
EP (1) EP0407955A1 (en)
JP (1) JPH03215489A (en)
KR (1) KR910002863A (en)
AU (1) AU636155B2 (en)
CA (1) CA2020806A1 (en)
FI (1) FI903509A0 (en)
HU (1) HUT59144A (en)
IE (1) IE902526A1 (en)
IL (1) IL95045A0 (en)
NO (1) NO903088L (en)
NZ (1) NZ234476A (en)
PL (1) PL286019A1 (en)
PT (1) PT94673A (en)
YU (1) YU133090A (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95708C (en) * 1988-10-31 1996-03-11 Eisai Co Ltd Analogous process for preparing a 1,4-diazepine derivative and its pharmaceutically acceptable salt
DE4027470A1 (en) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg NEW HETRAZEPINOIDE AMIDE
DE4101146A1 (en) * 1991-01-16 1992-07-23 Boehringer Ingelheim Kg NEW DIAZEPINE SUBSTITUTED IN 6-POSITION, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICAMENT
DE4107521A1 (en) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg NEW ACYLAMINOSUBSTITUTED HETRAZEPINE
DE69717160T2 (en) * 1996-09-13 2003-05-08 Mitsubishi Pharma Corp THIENOTRIAZOLODIAZEPINE COMPOUNDS AND THEIR MEDICAL APPLICATIONS
US5939432A (en) 1997-10-29 1999-08-17 Medco Research, Inc. Thiophenes useful for modulating the adenosine receptor
US6323214B1 (en) 1997-10-29 2001-11-27 Medco Research, Inc Allosteric adenosine receptor modulators
US6727258B2 (en) 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP5008796B2 (en) * 2001-01-19 2012-08-22 ダイト株式会社 Method for producing aromatic carboxylic acid
JP5159305B2 (en) * 2005-05-30 2013-03-06 田辺三菱製薬株式会社 Thienotriazolodiazepine compounds and their use as pharmaceuticals
ES2534521T3 (en) 2010-05-14 2015-04-23 Dana-Farber Cancer Institute, Inc. Compositions and their use in the treatment of neoplasia, inflammatory diseases and other diseases
EP2571875A4 (en) 2010-05-14 2013-10-30 Dana Farber Cancer Inst Inc Male contraceptive compositions and methods of use
AU2011252799B2 (en) 2010-05-14 2015-05-14 Cold Spring Harbor Laboratory Compositions and methods for treating leukemia
AR084070A1 (en) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc BROMODOMINIUM INHIBITORS AND USES OF THE SAME
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (en) 2012-06-06 2017-10-21 星宿藥物公司 Bromodomain inhibitors and uses thereof
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
KR20160034379A (en) 2013-07-25 2016-03-29 다나-파버 캔서 인스티튜트 인크. Inhibitors of transcription factors and uses thereof
CN105849110B (en) 2013-11-08 2019-08-02 达纳-法伯癌症研究所有限公司 Use the combination treatment for cancer of bromine structural domain and additional terminals (BET) protein inhibitor
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
CA2936865A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
MX2016011160A (en) 2014-02-28 2017-04-27 Tensha Therapeutics Inc Treatment of conditions associated with hyperinsulinaemia.
CA2952830C (en) 2014-06-20 2022-11-01 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
WO2016022970A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
CN106715437A (en) 2014-08-08 2017-05-24 达纳-法伯癌症研究所股份有限公司 Diazepane derivatives and uses thereof
EP3212654B1 (en) 2014-10-27 2020-04-08 Tensha Therapeutics, Inc. Bromodomain inhibitors
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CN108472300A (en) 2015-09-11 2018-08-31 达纳-法伯癌症研究所股份有限公司 Cyano thiophene and triazol diazacyclo heptantriene and application thereof
JP2018526424A (en) 2015-09-11 2018-09-13 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド Acetamidhienotriazolodiazepines and their use
SG10201913450PA (en) 2015-11-25 2020-03-30 Dana Farber Cancer Inst Inc Bivalent bromodomain inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2712951A1 (en) * 1977-03-24 1978-10-05 Bosch Gmbh Robert BIMETAL WITH AN ELECTRIC HEATING ELEMENT
DE3701344A1 (en) * 1986-01-21 1987-07-23 Boehringer Ingelheim Kg Novel thieno-1,4-diazepines
DE3778559D1 (en) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg THIENO-1,4-DIAZEPINE.
DE3610848A1 (en) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg NEW 1,4-DIAZEPINE
DE3724031A1 (en) * 1986-07-22 1988-01-28 Boehringer Ingelheim Kg Novel hetrazepines and process for their preparation
DE3624779C2 (en) * 1986-07-22 1996-03-07 Boehringer Ingelheim Kg Process for the preparation of thieno-triazolo-1,4-diazepino-2-carboxylic acid amides

Also Published As

Publication number Publication date
HUT59144A (en) 1992-04-28
KR910002863A (en) 1991-02-26
EP0407955A1 (en) 1991-01-16
CA2020806A1 (en) 1991-01-13
IE902526A1 (en) 1991-02-13
NO903088L (en) 1991-01-14
PT94673A (en) 1991-03-20
NO903088D0 (en) 1990-07-11
IL95045A0 (en) 1991-06-10
AU636155B2 (en) 1993-04-22
AU5892490A (en) 1991-01-17
YU133090A (en) 1993-10-20
JPH03215489A (en) 1991-09-20
PL286019A1 (en) 1991-10-21
HU904169D0 (en) 1990-12-28
FI903509A0 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
NZ234476A (en) Paf antagonist thienodiazepine derivatives; intermediates, pharmaceutical compositions and preparatory processes
NZ234854A (en) Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof
NZ235669A (en) 6-(substituted phenyl)-2-oxopyridine derivatives; pharmaceutical compositions and preparatory processes
EP0419653A4 (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
NZ236582A (en) Azaoxindole derivatives, pharmaceutical compositions and intermediates
GB8904182D0 (en) Pharmaceutical compositions
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
GB8909022D0 (en) Pharmaceutical compositions
NZ214532A (en) Aminoacyllabdanes, preparatory processes, intermediates for their preparation and pharmaceutical compositions
GB8917687D0 (en) Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
EP0441036A3 (en) Quinoline derivatives, processes for their preparation, intermediates, and pharmaceutical compositions containing these derivatives
NZ226337A (en) Substituted alkadiene derivatives, processes for their preparation, and pharmaceutical compositions
NZ234395A (en) 4-(1,2-dihydro-2-oxo-3-pyridyl) chroman derivatives, preparatory processes and pharmaceutical compositions
EP0285089A3 (en) 4-thioquinazoline derivatives, processes for their preparation and pharmaceutical compositions
GB2235198B (en) Novel aminopropanol derivatives,process for their preparation and pharmaceutical compositions comprising the same
NZ242464A (en) 2-aminopyrimidine-4-carboxamide derivatives; preparatory processes and pharmaceutical compositions
EP0409499A3 (en) Pharmaceutical compositions
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
ZA902591B (en) Thiouracil derivatives,pharmaceutical compositions containing them and process for preparing same
NZ220347A (en) Triazole derivatives, pharmaceutical compositions and intermediates
IL95088A0 (en) Pyrroloquinoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL110553A0 (en) Process for the preparation of 9-amino camptothecin, pharmaceutical compositions containing it and certain intermediates
ZA902316B (en) 5-acylbenzoxazolinone derivatives,processes for preparing them and pharmaceutical compositions containing them
NZ234489A (en) Thiazole-substituted cephalosporin derivatives; pharmaceutical compositions and preparatory processes
GB8909906D0 (en) Pharmaceutical compositions